Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Analyst Bursts Edwards’ Bubble On PARTNER Percutaneous Valve Trial

This article was originally published in The Gray Sheet

Executive Summary

An analyst raised doubts last week about Edwards Lifesciences' ability to gain approval for all studied indications in its closely watched U.S. trial for the Sapien percutaneous aortic valve

You may also be interested in...



Medtronic Catapults Into Transcatheter Valve Market With Billion-Dollar Buys

Medtronic will enter the high-growth, minimally invasive aortic heart valve market through two acquisitions worth more than $1 billion

Medtronic Catapults Into Transcatheter Valve Market With Billion-Dollar Buys

Medtronic will enter the high-growth, minimally invasive aortic heart valve market through two acquisitions worth more than $1 billion

Edwards’ Sapien Sales Drive 24% Gain In Q2 Heart Valve Revenue

Edwards Lifesciences' heart valve sales soared 24% in the second quarter from a year ago, to $162.6 million, driven by European sales of its Sapien transcatheter heart valve, the company says

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026426

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel